Sign in

CIK 0001453687

  • Non-accelerated filer
  • Smaller reporting company

Cartesian Therapeutics, Inc.

Sign in to watch
Ticker
RNAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-348-8698
Business address
7495 NEW HORIZON WAY, FREDERICK, MD, 21703
Former names
SELECTA BIOSCIENCES INC
  1. 4 Open-market sale President and CEO sold 41,070 shares at an average $1.13 ($46,501)
  2. 4 Open-market sale Chief Operations Officer sold 9,784 shares at an average $1.13 ($11,077)
  3. 4 Open-market sale Chief Scientific Officer sold 9,784 shares at an average $1.13 ($11,077)
  4. 4 Open-market sale Chief Medical Officer sold 11,644 shares at an average $1.13 ($13,185)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Grant or award President and CEO acquired 282,800 shares (grant or award)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award Chief Operations Officer acquired 100,000 shares (grant or award)
  12. 4 Grant or award Chief Scientific Officer acquired 100,000 shares (grant or award)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award Chief Medical Officer acquired 200,000 shares (grant or award)
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market sale President and CEO sold 4,522 shares at $1.33 ($6,014)
  18. 4 Option exercise President and CEO acquired 10,938 shares (option exercise)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 7 of 21 · 410 filings